Latest News

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Georgia State University will host the First International Triple Negative Breast Cancer Conference from Sept. 18 to 20.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Sex-changing fish exhibit differences in androgen receptor (AR) expression in muscles that are highly sensitive to androgens (male sex hormones) and essential for male courtship behavior, according to a Georgia State University study.

• share
• favorite_border

• share
• favorite_border

A Georgia State University researcher, in collaboration with researchers at the University of Pennsylvania and Florida State University, has received a five-year, $7.7 million federal grant to study the consequences of West Nile and Zika virus infections on the human central nervous system.

• share
• favorite_border

Scientists at Georgia State University have rewired the neural circuit of one species and given it the connections of another species to test a hypothesis about the evolution of neural circuits and behavior.

• share
• favorite_border

In humans, developing metabolic disease, particularly type 2 diabetes, is correlated with having bacteria that penetrate the mucus lining of the colon, according to a study led by Drs. Benoit Chassaing and Andrew Gewirtz at Georgia State University.

• share
• favorite_border

Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.

• share
• favorite_border

After a tax cut for the middle class by the end of 2017, expect gross domestic product (GDP) growth above 2 percent in 2018 and 2019, according to Rajeev Dhawan of the Economic Forecasting Center at Georgia State University’s J. Mack Robinson College of Business.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Dr. Jian-Dong Li, director of the Institute for Biomedical Sciences (IBMS) at Georgia State University and a Georgia Research Alliance Eminent Scholar, has been appointed to serve on the National Institutes of Health (NIH) Council of Councils (CoC).

• share
• favorite_border

• share
• favorite_border

Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has received a five-year, $2.3 million federal grant to study how to reduce tumor growth in lung cancer.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Researchers from Georgia State University’s Center for Molecular & Translational Medicine have received a four-year, $2.8 million federal grant to study diabetic cardiomyopathy, diabetes-related changes in the structure and function of the heart muscle.

• share
• favorite_border

A certain cytokine, or small protein that helps cells communicate during immune responses, can control whether immune cells promote or suppress inflammatory bowel disease, a finding that could lead to new treatments, according to a study led by Georgia State University.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

The gap in the high school dropout rate among students of different racial and demographic backgrounds narrows when certain variables, such as socioeconomic status and school size, are the same, according to a Georgia State University study.

• share
• favorite_border

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

• share
• favorite_border

• share
• favorite_border

A female brain’s resident immune cells are more active in regions involved in pain processing relative to males, according to a recent study by Georgia State University researchers.

• share
• favorite_border

A person’s sex and running ability play a role in the decline of their performance in marathons as they get older, according to a Georgia State University study.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

The Institute for Biomedical Sciences (IBMS) at Georgia State University is offering two new graduate degree programs designed to prepare students for careers in the biomedical sciences that will enhance human health and bring scientific discoveries to market.

• share
• favorite_border

• share
• favorite_border

Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn’t influence disease outcomes in white patients, according to a new study.

• share
• favorite_border

Noma LeMoine, chief educational officer of LeMoine and Associates Educational Consulting, will deliver the 28th annual Benjamin E. Mays Lecture on Feb. 21 at 6:30 p.m. in the Georgia State University Student Center East Ballroom (55 Gilmer St. SE, Atlanta).

• share
• favorite_border

Dr. Anne Murphy, a neuroscientist of Georgia State University, has received a five-year, $1.8 million grant from the National Institutes of Health (NIH), to investigate pain management therapies for people aged 65 or older.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study.